| ELK.No | ES13269 |
| Product name | S13A5 rabbit pAb |
| Reactivity | Human; Mouse;Rat |
| Applications | WB |
| Other name | Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter) |
| Size | 100μL |
| Unit price ($) | 248 |
| Human gene ID | 284111 |
| Human Swiss-Prot | Q86YT5 |
| Source | Rabbit |
| Isotype | IgG |
| Target | S13A5 |
| Fields | |
| Gene name | SLC13A5 NACT |
| Protein name | S13A5 |
| Human gene link | View Human Gene |
| Human Swiss link | View Human Swiss-Prot |
| Mouse gene ID | 237831 |
| Mouse gene link | View Mouse Gene |
| Mouse Swiss-Prot | Q67BT3 |
| Mouse Swiss link | View Mouse Swiss-Prot |
| Rat gene ID | 266998 |
| Rat gene link | View Rat Gene |
| Rat Swiss-Prot | Q8CJ44 |
| Rat Swiss link | View Rat Swiss-Prot |
| Immunogen | Synthesized peptide derived from human S13A5 AA range: 313-363 |
| Specificity | This antibody detects endogenous levels of S13A5 at Human/Mouse/Rat |
| Formulation | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.157% sodium azide. |
| Clonality | Polyclonal |
| Dilution | WB 1:500-2000 |
| Purification | The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen. |
| Concentration | 1 mg/ml |
| Storage stability | -20°C/1 year |
| Molecular Weight (Da) | |
| Observed band (KD) | 60kD |
| Background | This gene encodes a protein belonging to the solute carrier family 13 group of proteins. This family member is a sodium-dependent citrate cotransporter that may regulate metabolic processes. Mutations in this gene cause early infantile epileptic encephalopathy 25. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2014], |
| Function | function:High-affinity sodium/citrate cotransporter that mediates citrate entry into cells. The transport process is electrogenic; it is the trivalent form of citrate rather than the divalent form that is recognized as a substrate. May facilitate the utilization of circulating citrate for the generation of metabolic energy and for the synthesis of fatty acids and cholesterol.,similarity:Belongs to the SLC13A transporter (TC 2.A.47) family. NADC subfamily.,tissue specificity:Expressed most predominantly in the liver, with moderate expression detectable in the brain and testis., |
| Subcellular location | Cell membrane ; Multi-pass membrane protein . |
| Expression | Expressed most predominantly in the liver, with moderate expression detectable in the brain and testis. |

Use collapsible tabs for more detailed information that will help customers make a purchasing decision.
Ex: Shipping and return policies, size guides, and other common questions.